These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27349790)

  • 1. Novel high/low solubility classification methods for new molecular entities.
    Dave RA; Morris ME
    Int J Pharm; 2016 Sep; 511(1):111-126. PubMed ID: 27349790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
    Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
    Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDDCS class prediction for new molecular entities.
    Broccatelli F; Cruciani G; Benet LZ; Oprea TI
    Mol Pharm; 2012 Mar; 9(3):570-80. PubMed ID: 22224483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver.
    Plöger GF; Hofsäss MA; Dressman JB
    J Pharm Sci; 2018 Jun; 107(6):1478-1488. PubMed ID: 29421214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
    Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
    J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDDCS applied to over 900 drugs.
    Benet LZ; Broccatelli F; Oprea TI
    AAPS J; 2011 Dec; 13(4):519-47. PubMed ID: 21818695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples.
    Papadopoulou V; Valsami G; Dokoumetzidis A; Macheras P
    Int J Pharm; 2008 Sep; 361(1-2):70-7. PubMed ID: 18614303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
    Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
    Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.
    Golfar Y; Shayanfar A
    J Pharm Pharm Sci; 2019; 22(1):247-269. PubMed ID: 31287788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provisional biopharmaceutical classification of some common herbs used in Western medicine.
    Waldmann S; Almukainzi M; Bou-Chacra NA; Amidon GL; Lee BJ; Feng J; Kanfer I; Zuo JZ; Wei H; Bolger MB; Löbenberg R
    Mol Pharm; 2012 Apr; 9(4):815-22. PubMed ID: 22352942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational models to assign biopharmaceutics drug disposition classification from molecular structure.
    Khandelwal A; Bahadduri PM; Chang C; Polli JE; Swaan PW; Ekins S
    Pharm Res; 2007 Dec; 24(12):2249-62. PubMed ID: 17846869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
    Benet LZ
    J Pharm Sci; 2013 Jan; 102(1):34-42. PubMed ID: 23147500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.
    Bocci G; Oprea TI; Benet LZ
    AAPS J; 2022 Feb; 24(2):37. PubMed ID: 35199251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-binary biopharmaceutical classification of drugs: the ABΓ system.
    Macheras P; Karalis V
    Int J Pharm; 2014 Apr; 464(1-2):85-90. PubMed ID: 24456673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purely in silico BCS classification: science based quality standards for the world's drugs.
    Dahan A; Wolk O; Kim YH; Ramachandran C; Crippen GM; Takagi T; Bermejo M; Amidon GL
    Mol Pharm; 2013 Nov; 10(11):4378-90. PubMed ID: 24094040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
    Hosey CM; Chan R; Benet LZ
    AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS).
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):751-7. PubMed ID: 17637167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).
    Li J; Larregieu CA; Benet LZ
    Chin J Nat Med; 2016 Dec; 14(12):888-897. PubMed ID: 28262115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.